The Microbiology of Coronaviruses

The end of 2019 marked the start of coronavirus disease (COVID-19) pandemic from China, which went on to envelope more than 190 countries and territories across the globe. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), from a group of betacoronaviruses, is responsible for COVID-19. The virulent factors include the presence of envelope and spike proteins having receptor bonding domains (RBD). Clinical manifestations can range from mild respiratory infections to fatal outcomes. The viability of virus ranges from 3 to 72 hours. Polymerase chain reaction (PCR) is the diagnostic test of choice in this pandemic situation. Due to the absence of specific antivirals and vaccine, adoption of preventive option can help to combat the specific life-threatening outcomes.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:70(Suppl 3)

Enthalten in:

JPMA. The Journal of the Pakistan Medical Association - 70(Suppl 3)(2020), 5 vom: 09. Mai, Seite S44-S47

Sprache:

Englisch

Beteiligte Personen:

Zafar, Humaira [VerfasserIn]

Links:

Volltext

Themen:

COVID-19 Vaccines
Coronaviruses, SARS-CoV- 2, Respiratory Infections, Receptor Binding Domains, Angiotensin Converting Enzyme 2, Pandemic.
Journal Article
Viral Vaccines

Anmerkungen:

Date Completed 18.06.2020

Date Revised 18.12.2020

published: Print

Citation Status MEDLINE

doi:

10.5455/JPMA.08

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310948126